CHANGES IN SEROTONIN-INDUCED POTENTIALS DURING SPINAL-CORD DEVELOPMENT

被引:64
作者
ZISKINDCONHAIM, L [1 ]
SEEBACH, BS [1 ]
GAO, BX [1 ]
机构
[1] UNIV WISCONSIN, CTR NEUROSCI, MADISON, WI 53706 USA
关键词
D O I
10.1152/jn.1993.69.4.1338
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1. Motoneuron responses to serotonin (5-hydroxytryptamine, 5-HT), and the growth pattern of 5-HT projections into the ventral horn were studied in the isolated spinal cord of embryonic and neonatal rats. 2. 5-HT projections first appeared in lumbar spinal cord at days 16-17 of gestation (E16-E17) and were localized in the lateral and ventral funiculi. By E18, the projections had grown into the ventral horn, and at 1-2 days after birth they were in close apposition to motoneuron somata. 3. At E16-E17, slow-rising depolarizing potentials of 1-4 mV were recorded intracellularly in lumbar motoneurons in response to bath application of 5-HT. These potentials were not apparent after E18; at that time 5-HT generated long-lasting depolarizations with an average amplitude of 6 mV, and an increase of 11% in membrane resistance. Starting at E18, 5-HT also induced high-frequency fast-rising potentials that were blocked by antagonists of glutamate, gamma-aminobutyric acid, and glycine. 4. Motoneuron responses to 5-HT increased significantly after birth, when 5-HT produced an average depolarization of 19 mV and repetitive firing of action potentials. 5. Tetrodotoxin and high Mg2+ did not reduce the amplitude of the long-lasting depolarizations, which suggested that they were produced by direct action of 5-HT on motoneuron membrane. 6. At all developmental ages, 5-HT reduced the amplitude of dorsal root-evoked potentials. The suppressed responses were neither due to 5-HT-induced depolarization nor the result of a decrease in motoneuron excitability. 7. The pharmacological profile of 5-HT-induced potentials was studied with the use of various agonists and antagonists of 5-HT. The findings indicated that the actions of 5-HT on spinal neurons were mediated via multiple 5-HT receptor subtypes. 8. Our results suggested that 5-HT excited spinal neurons be fore 5-HT projections grew into the ventral horn. The characteristics of 5-HT-induced potentials changed, however, at the time when the density of 5-HT projections increased in the motor nuclei.
引用
收藏
页码:1338 / 1349
页数:12
相关论文
共 63 条
[1]   PHARMACOLOGICALLY DISTINCT ACTIONS OF SEROTONIN ON SINGLE PYRAMIDAL NEURONS OF THE RAT HIPPOCAMPUS RECORDED INVITRO [J].
ANDRADE, R ;
NICOLL, RA .
JOURNAL OF PHYSIOLOGY-LONDON, 1987, 394 :99-124
[2]   MODIFICATION OF LUMBAR MOTONEURON EXCITABILITY BY STIMULATION OF A PUTATIVE 5-HYDROXYTRYPTAMINE PATHWAY [J].
BARASI, S ;
ROBERTS, MHT .
BRITISH JOURNAL OF PHARMACOLOGY, 1974, 52 (03) :339-348
[3]   ION CONDUCTANCES AFFECTED BY 5-HT RECEPTOR SUBTYPES IN MAMMALIAN NEURONS [J].
BOBKER, DH ;
WILLIAMS, JT .
TRENDS IN NEUROSCIENCES, 1990, 13 (05) :169-173
[4]   SEROTONIN AUGMENTS THE CATIONIC CURRENT IH IN CENTRAL NEURONS [J].
BOBKER, DH ;
WILLIAMS, JT .
NEURON, 1989, 2 (06) :1535-1540
[5]   DESCENDING SEROTONERGIC, PEPTIDERGIC AND CHOLINERGIC PATHWAYS FROM THE RAPHE NUCLEI - A MULTIPLE TRANSMITTER COMPLEX [J].
BOWKER, RM ;
WESTLUND, KN ;
SULLIVAN, MC ;
WILBER, JF ;
COULTER, JD .
BRAIN RESEARCH, 1983, 288 (1-2) :33-48
[6]   COMPARISON OF EFFECTS OF VARIOUS TYPES OF NA AND 5-HT AGONISTS ON TRANSMISSION FROM GROUP-II MUSCLE AFFERENTS IN THE CAT [J].
BRAS, H ;
JANKOWSKA, E ;
NOGA, B ;
SKOOG, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1990, 2 (12) :1029-1039
[7]   DEVELOPMENT OF SEROTONIN IMMUNOREACTIVITY IN THE RAT SPINAL-CORD AND ITS PLASTICITY AFTER NEONATAL SPINAL-CORD LESIONS [J].
BREGMAN, BS .
DEVELOPMENTAL BRAIN RESEARCH, 1987, 34 (02) :245-263
[8]   ULTRASTRUCTURAL IMMUNOCYTOCHEMICAL CO-LOCALIZATION OF SEROTONIN AND PNMT IN ADRENAL-MEDULLARY VESICLES [J].
BROWNFIELD, MS ;
POFF, BC ;
HOLZWARTH, MA .
HISTOCHEMISTRY, 1985, 83 (01) :41-46
[9]   ACTIVATION OF BRAIN-STEM SEROTONINERGIC PATHWAYS DECREASES HOMOSYNAPTIC DEPRESSION OF MONO-SYNAPTIC RESPONSES OF FROG SPINAL MOTONEURONS [J].
CARDONA, A ;
RUDOMIN, P .
BRAIN RESEARCH, 1983, 280 (02) :373-378
[10]  
CLINESCHMIDT BV, 1971, J PHARMACOL EXP THER, V179, P312